Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 139

1.

Levocarnitine administration in multiple sclerosis patients with immunosuppressive therapy-induced fatigue.

Lebrun C, Alchaar H, Candito M, Bourg V, Chatel M.

Mult Scler. 2006 Jun;12(3):321-4.

PMID:
16764345
[PubMed - indexed for MEDLINE]
2.

Fatigue characteristics in multiple sclerosis: the North American Research Committee on Multiple Sclerosis (NARCOMS) survey.

Hadjimichael O, Vollmer T, Oleen-Burkey M; North American Research Committee on Multiple Sclerosis.

Health Qual Life Outcomes. 2008 Nov 14;6:100. doi: 10.1186/1477-7525-6-100.

PMID:
19014588
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

A randomized crossover study of bee sting therapy for multiple sclerosis.

Wesselius T, Heersema DJ, Mostert JP, Heerings M, Admiraal-Behloul F, Talebian A, van Buchem MA, De Keyser J.

Neurology. 2005 Dec 13;65(11):1764-8. Epub 2005 Oct 12.

PMID:
16221950
[PubMed - indexed for MEDLINE]
4.

Potential role of levocarnitine supplementation for the treatment of chemotherapy-induced fatigue in non-anaemic cancer patients.

Graziano F, Bisonni R, Catalano V, Silva R, Rovidati S, Mencarini E, Ferraro B, Canestrari F, Baldelli AM, De Gaetano A, Giordani P, Testa E, Lai V.

Br J Cancer. 2002 Jun 17;86(12):1854-7.

PMID:
12085175
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial.

Tomassini V, Pozzilli C, Onesti E, Pasqualetti P, Marinelli F, Pisani A, Fieschi C.

J Neurol Sci. 2004 Mar 15;218(1-2):103-8.

PMID:
14759641
[PubMed - indexed for MEDLINE]
6.

Interferon treatment may trigger primary headaches in multiple sclerosis patients.

La Mantia L, D'Amico D, Rigamonti A, Mascoli N, Bussone G, Milanese C.

Mult Scler. 2006 Aug;12(4):476-80.

PMID:
16900761
[PubMed - indexed for MEDLINE]
7.

Impact of disease-modifying treatments in North African migrants with multiple sclerosis in France.

Lebrun C, Debouverie M, Jeannin S, Pittion-Vouyovitch S, Bayreuther C, Berthier F.

Mult Scler. 2008 Aug;14(7):933-9. doi: 10.1177/1352458508091369. Epub 2008 Jun 23.

PMID:
18573824
[PubMed - indexed for MEDLINE]
8.

Serum carnitine and disabling fatigue in multiple sclerosis.

Fukazawa T, Sasaki H, Kikuchi S, Hamada T, Tashiro K.

Psychiatry Clin Neurosci. 1996 Dec;50(6):323-5.

PMID:
9014230
[PubMed - indexed for MEDLINE]
9.

L-carnitine supplementation for the treatment of fatigue and depressed mood in cancer patients with carnitine deficiency: a preliminary analysis.

Cruciani RA, Dvorkin E, Homel P, Culliney B, Malamud S, Shaiova L, Fleishman S, Lapin J, Klein E, Lesage P, Portenoy R, Esteban-Cruciani N.

Ann N Y Acad Sci. 2004 Nov;1033:168-76.

PMID:
15591014
[PubMed - indexed for MEDLINE]
10.

Escalating immunotherapy with mitoxantrone in patients with very active relapsing-remitting or progressive multiple sclerosis.

Cursiefen S, Flachenecker P, Toyka KV, Rieckmann P.

Eur Neurol. 2000;43(3):186-7. No abstract available.

PMID:
10765063
[PubMed - indexed for MEDLINE]
11.

Clinical follow-up of 304 patients with multiple sclerosis three years after mitoxantrone treatment.

Debouverie M, Taillandier L, Pittion-Vouyovitch S, Louis S, Vespignani H.

Mult Scler. 2007 Jun;13(5):626-31. Epub 2007 Feb 9.

PMID:
17548442
[PubMed - indexed for MEDLINE]
12.

Severe delayed heart failure in three multiple sclerosis patients previously treated with mitoxantrone.

Goffette S, van Pesch V, Vanoverschelde JL, Morandini E, Sindic CJ.

J Neurol. 2005 Oct;252(10):1217-22. Epub 2005 Apr 18.

PMID:
15834643
[PubMed - indexed for MEDLINE]
13.

Mitoxantrone versus cyclophosphamide in secondary-progressive multiple sclerosis: a comparative study.

Perini P, Calabrese M, Tiberio M, Ranzato F, Battistin L, Gallo P.

J Neurol. 2006 Aug;253(8):1034-40. Epub 2006 Apr 11.

PMID:
16609811
[PubMed - indexed for MEDLINE]
14.

Exploratory open label, randomized study of acetyl- and propionylcarnitine in chronic fatigue syndrome.

Vermeulen RC, Scholte HR.

Psychosom Med. 2004 Mar-Apr;66(2):276-82.

PMID:
15039515
[PubMed - indexed for MEDLINE]
15.

Multiple sclerosis in Pakistan.

Wasay M, Ali S, Khatri IA, Hassan A, Asif M, Zakiullah N, Ahmed A, Malik A, Khealani B, Haq A, Fredrikson S.

Mult Scler. 2007 Jun;13(5):668-9. Epub 2007 Feb 9.

PMID:
17548448
[PubMed - indexed for MEDLINE]
16.

Cost-effectiveness of four immunomodulatory therapies for relapsing-remitting multiple sclerosis: a Markov model based on long-term clinical data.

Bell C, Graham J, Earnshaw S, Oleen-Burkey M, Castelli-Haley J, Johnson K.

J Manag Care Pharm. 2007 Apr;13(3):245-61.

PMID:
17407391
[PubMed - indexed for MEDLINE]
Free Article
17.

Deep gray matter perfusion in multiple sclerosis: dynamic susceptibility contrast perfusion magnetic resonance imaging at 3 T.

Inglese M, Park SJ, Johnson G, Babb JS, Miles L, Jaggi H, Herbert J, Grossman RI.

Arch Neurol. 2007 Feb;64(2):196-202.

PMID:
17296835
[PubMed - indexed for MEDLINE]
18.

L-Carnitine in the treatment of fatigue in adult celiac disease patients: a pilot study.

Ciacci C, Peluso G, Iannoni E, Siniscalchi M, Iovino P, Rispo A, Tortora R, Bucci C, Zingone F, Margarucci S, Calvani M.

Dig Liver Dis. 2007 Oct;39(10):922-8. Epub 2007 Aug 10.

PMID:
17693145
[PubMed - indexed for MEDLINE]
19.

Increased serum levels of soluble CD14 indicate stable multiple sclerosis.

Lutterotti A, Kuenz B, Gredler V, Khalil M, Ehling R, Gneiss C, Egg R, Deisenhammer F, Berger T, Reindl M.

J Neuroimmunol. 2006 Dec;181(1-2):145-9. Epub 2006 Oct 13.

PMID:
17046070
[PubMed - indexed for MEDLINE]
20.

Treatment patterns of multiple sclerosis patients: a comparison of veterans and non-veterans using the NARCOMS registry.

Lo AC, Hadjimichael O, Vollmer TL.

Mult Scler. 2005 Feb;11(1):33-40.

PMID:
15732264
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk